IMMUNOGLOBULIN G1 (HUMAN-RAT MONOCLONAL CAMPATH-1H .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD52), DISULFIDE WITH HUMAN-RAT MONOCLONAL CAMPATH-1H LIGHT CHAIN, DIMER
Childhood Burkitt Lymphoma
Fred Hutchinson Cancer Centermonoclonal_antibodyPhase 2Dormant
B
61/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 46/ 100
- Competitive Position
- 95/ 100
Competitive context
74 Active assets in the Childhood Burkitt Lymphoma cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
FILGRASTIM Fred Hutchinson Cancer Center | Phase 4 | BBB |
VINCRISTINE SULFATE AIDS Malignancy Consortium | Phase 2 | BBB |
VINDESINE PETHEMA Foundation | Phase 4 | BBB |
CYCLOSPORIN A Fred Hutchinson Cancer Center | Phase 2 | BBB |
Cyclophosphamide AIDS Malignancy Consortium | Phase 4 | BBB |
View all 50 →
Same molecule, other indications
IMMUNOGLOBULIN G1 (HUMAN-RAT MONOCLONAL CAMPATH-1H .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD52), DISULFIDE WITH HUMAN-RAT MONOCLONAL CAMPATH-1H LIGHT CHAIN, DIMER is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →